OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update
WALTHAM, Mass., Jan. 09, 2024 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the “Company”) (Nasdaq:OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced select preliminary unaudited financials for 2023 and is providing the following business update.
Related news for (OPRX)
- OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors
- OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report
- OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET
- OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment
- Today’s Top Performers: MoBot’s Market Review 03/12/25 09:00 AM